chr16-28866187-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001387430.1(SH2B1):āc.93G>Cā(p.Glu31Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000000703 in 1,423,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes š: 7.0e-7 ( 0 hom. )
Consequence
SH2B1
NM_001387430.1 missense
NM_001387430.1 missense
Scores
3
12
4
Clinical Significance
Conservation
PhyloP100: 4.96
Genes affected
SH2B1 (HGNC:30417): (SH2B adaptor protein 1) This gene encodes a member of the SH2-domain containing mediators family. The encoded protein mediates activation of various kinases and may function in cytokine and growth factor receptor signaling and cellular transformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.887
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SH2B1 | NM_001387430.1 | c.93G>C | p.Glu31Asp | missense_variant | 1/8 | ENST00000684370.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SH2B1 | ENST00000684370.1 | c.93G>C | p.Glu31Asp | missense_variant | 1/8 | NM_001387430.1 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000542 AC: 1AN: 184398Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 101774
GnomAD3 exomes
AF:
AC:
1
AN:
184398
Hom.:
AF XY:
AC XY:
0
AN XY:
101774
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 7.03e-7 AC: 1AN: 1423388Hom.: 0 Cov.: 36 AF XY: 0.00000142 AC XY: 1AN XY: 705424
GnomAD4 exome
AF:
AC:
1
AN:
1423388
Hom.:
Cov.:
36
AF XY:
AC XY:
1
AN XY:
705424
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SH2B1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 06, 2024 | The SH2B1 c.93G>C variant is predicted to result in the amino acid substitution p.Glu31Asp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0022% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M;.;M;M;M
MutationTaster
Benign
D;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;N;D;.;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;.;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D
Polyphen
0.99, 0.99
.;D;D;.;D;D;D
Vest4
0.77, 0.62, 0.74, 0.77
MutPred
Gain of MoRF binding (P = 0.1296);Gain of MoRF binding (P = 0.1296);Gain of MoRF binding (P = 0.1296);Gain of MoRF binding (P = 0.1296);Gain of MoRF binding (P = 0.1296);Gain of MoRF binding (P = 0.1296);Gain of MoRF binding (P = 0.1296);
MVP
MPC
0.82
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at